Calvin Sandra bought TVTX
April 14, 2026 · Form 4 insider transaction
Calvin Sandra bought 6,250 shares of Travere Therapeutics, Inc. at $8.93 per share, a transaction worth $55.8K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
6,250
Price
$8.93
Total value
$55.8K
InsiderCalvin Sandra
RoleOfficer
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateApril 14, 2026
Filing dateApril 16, 2026
Shares owned after57,830
OwnershipDirect
10b5-1 planNo
AmendedNo